The Enterprise Value as of December 2025 (TTM) for SynAct Pharma AB (SYNACT.ST) is 1.02B

According to SynAct Pharma AB’s latest financial reports and current stock price. The company's current Enterprise Value is 1.02B. This represents a change of 36.11% compared to the average of 752.87M of the last 4 quarters.

SynAct Pharma AB (SYNACT.ST) Historical Enterprise Value (quarterly & annually)

How has SYNACT.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of SynAct Pharma AB over the last ten years is 768.29M. The current 1.02B Enterprise Value has changed 13.24% with respect to the historical average. Over the past ten years (40 quarters), SYNACT.ST's Enterprise Value was at its highest in in the December 2021 quarter at 3.68B. The Enterprise Value was at its lowest in in the December 2016 quarter at 44.87M.

SynAct Pharma AB (SYNACT.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of SynAct Pharma AB Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SynAct Pharma AB (SYNACT.ST) Average Enterprise Value

How has SYNACT.ST Enterprise Value performed in the past?

The current Enterprise Value of SynAct Pharma AB (SYNACT.ST) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

SynAct Pharma AB (SYNACT.ST) Enterprise Value vs. Peers

How is SYNACT.ST’s Enterprise Value compared to its peers?

SynAct Pharma AB’s Enterprise Value is less than Oncopeptides AB (publ) (1.09B), less than Xspray Pharma AB (publ) (1.09B), greater than I-Tech AB (518.33M), greater than Infant Bacterial Therapeutics AB (publ) (485.65M), less than Diamyd Medical AB (publ) (1.07B), less than Genovis AB (publ.) (1.27B), less than Orexo AB (publ) (1.25B), greater than Sedana Medical AB (publ) (943.08M), greater than Cantargia AB (publ) (756.00M), greater than C-Rad AB (publ) (861.14M),

Build a custom stock screener for SynAct Pharma AB (SYNACT.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SynAct Pharma AB using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SynAct Pharma AB (SYNACT.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SynAct Pharma AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.